Also Announces Extension of IR Program VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Onco-Innovations Limited (CBOE CA:ONCO ...
Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per monthBrief Summary:GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per ...
New Foundation Trustees and Company Board Appointed to Oversee Knoa Pharma’s Public Health Purpose; Company Board to Ensure ...
LINCOLN, NE / ACCESS Newswire / May 1, 2026 / Securitas Healthcare, a leading provider of real‑time visibility and protection ...
Collaboration Demonstrates Sequenex’s Commitment to Innovation in Medical TechnologyLOS ANGELES & ATLANTA--(BUSINESS ...
Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced it will present new data related to ...
Acquisition strengthens embedded research ERO model, expands network to 35+ sites across six states OXNARD, CA / ACCESS ...
TaeWoong Medical USA today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Niti-S SPAXUS™ Stent, further strengthening its portfolio of endoscopic ultrasound ...
Affiliates of funds advised by SK Capital Partners, LP (“SK Capital”), a private investment firm focused on the life sciences, specialty materials, and ingredients sectors announced today they have ...
MESA, AZ / ACCESS Newswire / May 1, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) ("the Company") today announced ...
Independent Pharmacy Cooperative and Doctronic unite to power pharmacy-led, AI-enabled telehealth-expanding access, improving continuity of care, and keeping pharmacists at the center of patient ...
National nonprofit marks milestone with call to action to expand impact nationwide BARNARD, VT / ACCESS Newswire / May 1, 2026 / For nearly 50 years, treatment options for osteosarcoma, a rare form of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results